SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,663,986 | +1107.9% | 77,924 | +879.8% | 0.01% | +550.0% |
| Q4 2022 | $303,327 | -76.2% | 7,953 | -72.3% | 0.00% | -87.5% |
| Q3 2021 | $1,272,000 | +54.6% | 28,697 | +98.1% | 0.02% | +77.8% |
| Q2 2021 | $823,000 | -82.8% | 14,489 | -77.3% | 0.01% | -88.2% |
| Q1 2021 | $4,783,000 | +257.2% | 63,907 | +313.0% | 0.08% | +300.0% |
| Q4 2020 | $1,339,000 | +74.3% | 15,475 | -42.1% | 0.02% | -40.6% |
| Q1 2020 | $768,000 | – | 26,738 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |